<unk> s are unique nonproprietary names assigned to pharmaceuticals marketed in the<unk><unk> .  Each name is assigned by the<unk>  Council, which is co-sponsored by the American Medical Association (AMA), the<unk><unk>  Pharmacopoeial Convention (USP), and the American Pharmacists Association (APhA).
The goal of the<unk>  Council is to select simple, informative, and unique nonproprietary names (also called generic names) for drugs by establishing logical nomenclature classifications based on pharmacological and/or chemical relationships.  In addition to drugs, the<unk>  Council names agents for gene therapy and cell therapy, contact lens polymers, surgical materials, diagnostics, carriers, and substances used as an excipient.  The<unk>  Council works in conjunction with the World Health Organization (WHO) International Nonproprietary Name (INN) Expert Committee and national nomenclature groups to standardize drug nomenclature and establish rules governing the classification of new substances.
United States Adopted Name
Orphan patient
Page name
Healthcare in Cuba
Repugnant market
Cancer previvor
Healthcare in India
Mental health professional